MEGHAN SUTTON: Open Payments
NPI 1710367867 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$913 in 35 payments from 16 companies in 2025. Trend: 2023 $607 · 2024 $427 · 2025 $913
Food & beverage: $913
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 9 | $267 |
| Ferring Pharmaceuticals Inc. | 4 | $91 |
| ABBVIE INC. | 3 | $88 |
| Boston Scientific Corporation | 3 | $66 |
| Procept Biorobotics Corporation | 1 | $63 |
| Dendreon Pharmaceuticals LLC | 2 | $50 |
| 180 Medical, Inc. | 2 | $49 |
| COLOPLAST CORP | 2 | $38 |
| UROGEN PHARMA, INC. | 2 | $35 |
| Ethicon US, LLC | 1 | $32 |
Products named: GEMTESA, ADSTILADRIN, BOTOX, AQUABEAM ROBOTIC SYSTEM, PROVENGE, General - Erectile Dysfunction, STRATAFIX, Exparel.
Industry payments across TX — which companies pay providers there.
